Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study.
about
Cyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during TherapyCTNNB1 S45F mutation predicts poor efficacy of meloxicam treatment for desmoid tumors: a pilot study.YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcoma.Quantitative assessment of the association of COX-2 (Cyclooxygenase-2) immunoexpression with prognosis in human osteosarcoma: a meta-analysis.Analysis of gene expression in cyclooxygenase-2-overexpressed human osteosarcoma cell lines.Overexpression of cyclooxygenase-2 in malignant peripheral nerve sheath tumor and selective cyclooxygenase-2 inhibitor-induced apoptosis by activating caspases in human malignant peripheral nerve sheath tumor cells.Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.Suppression of the migration and invasion is mediated by triptolide in B16F10 mouse melanoma cells through the NF-kappaB-dependent pathway.Transition of treatment for patients with extra-abdominal desmoid tumors: nagoya university modality.Global gene expression analysis of canine osteosarcoma stem cells reveals a novel role for COX-2 in tumour initiation.Advances in the identification of molecular markers for bone neoplasia.Prognostic value of pathologic fracture in patients with high grade localized osteosarcoma: a systemic review and meta-analysis of cohort studies.EMMPRIN co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma.Cyclooxygeanse-2 promotes metastasis in osteosarcoma.Prognostic significance of cyclooxygenase-2 in osteosarcoma: a meta-analysis.
P2860
Q28073252-FC9B39C3-4BE0-44D4-AA77-AAEE6256B00FQ33553463-6D6F920E-B650-4B0F-AEB6-84C855EF37D9Q34065323-55C6660D-833D-4463-B80D-E59AA50369E0Q35072942-ED8B03F8-005B-4873-8282-4D78D28AC12BQ35088724-975204E0-FCD8-466D-BAAB-22E7CCF957ABQ35091515-AF97B77E-3A71-4207-ABB3-3562C6FA44BDQ35619493-9B50D10E-F937-42E5-B003-39A21A687DBAQ35792930-26D1D2F0-1781-4148-A6F3-95C020FFD3C6Q37016976-432EAE74-22B4-4C90-9DB7-4D6661599AF0Q37451879-8A71CDC0-B9D9-49A8-9DED-86CC95DAB20BQ38089888-DE4EFC22-C43C-4EE8-ACE6-4D12856F71BDQ38250874-2E30EB5A-C109-47EE-B035-E0E99E008A05Q39028706-BEF86F42-457D-4502-9C48-A54059231CE9Q41633107-F113297E-E3DE-44FF-AF8E-9FEC3A4BFB76Q44827493-8C86EE39-9440-4E05-821C-3FCD99E9BCFB
P2860
Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cyclooxygenase-2 overexpressio ...... y osteosarcoma: a pilot study.
@en
Cyclooxygenase-2 overexpressio ...... y osteosarcoma: a pilot study.
@nl
type
label
Cyclooxygenase-2 overexpressio ...... y osteosarcoma: a pilot study.
@en
Cyclooxygenase-2 overexpressio ...... y osteosarcoma: a pilot study.
@nl
prefLabel
Cyclooxygenase-2 overexpressio ...... y osteosarcoma: a pilot study.
@en
Cyclooxygenase-2 overexpressio ...... y osteosarcoma: a pilot study.
@nl
P2093
P2860
P1476
Cyclooxygenase-2 overexpressio ...... y osteosarcoma: a pilot study.
@en
P2093
Hiroatsu Nakashima
Hiroshi Urakawa
Naoki Ishiguro
Takahiro Naruse
Yoshihiro Nishida
P2860
P2888
P304
P356
10.1007/S11999-009-0814-X
P407
P577
2009-03-27T00:00:00Z